Influenza A virus nucleoprotein (NP) gene RNA (IAV NP RNA)

The Influenza A virus nucleoprotein (NP) gene RNA, which constitutes segment 5 of the viral genome, is a critical component for the replication and assembly of the influenza virus. This RNA encodes the nucleoprotein (NP), an essential multifunctional protein that encapsidates the viral RNA segments to form viral ribonucleoprotein (vRNP) complexes, which are the functional units for viral transcription and replication (Luo et al., 2012). Because the NP gene contains highly conserved sequences across various strains, including H1N1 and H5N1, it is a major focus for the development of sequence-specific antivirals (Ge et al., 2003). Therapeutic approaches primarily involve RNA interference (RNAi) using siRNAs or antisense oligonucleotides (ASOs) that target the NP mRNA or vRNA for degradation, thereby inhibiting the production of NP protein and halting the viral life cycle (Tompkins et al., 2004). While highly effective in preclinical models, the clinical application of targeting IAV NP RNA is challenged by the requirement for efficient delivery to the respiratory tract and the potential for the virus to escape through mutations (Sui et al., 2009).

Other names

Influenza A virus segment 5 RNAIAV NP mRNAIAV NP vRNANucleoprotein gene RNA

RNA interference (RNAi) leading to sequence-specific degradation of viral mRNA and genomic RNA; Antisense-mediated inhibition of translation and RNase H-dependent cleavage.